文献速递脊柱关节炎

强直性脊柱炎长期使用非甾体抗炎药与心血管疾病风险的相关性

Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究基于韩国国民健康保险数据库构建全国性人群队列,纳入2010年1月至2018年12月新诊断且无既往心血管疾病的≥18岁强直性脊柱炎患者19775例及按年龄、性别和索引年份随机匹配的无强直性脊柱炎对照59325例。长期使用非甾体抗炎药定义为累积限定日剂量>365。结果显示,长期使用非甾体抗炎药与非强直性脊柱炎对照组心血管疾病风险升高相关(aHR 1.64;95% CI 1.48-1.82),而在强直性脊柱炎患者中未增加心血管疾病风险(aHR 1.06;95% CI 0.94-1.20)。作者结论认为,强直性脊柱炎患者长期使用非甾体抗炎药的心血管风险可能不如一般人群那样有害。

要点

  • 强直性脊柱炎患者长期使用非甾体抗炎药(累积限定日剂量>365)与心血管疾病风险无显著关联(aHR 1.06;95% CI 0.94-1.20)。
  • 非强直性脊柱炎对照长期使用非甾体抗炎药与心血管疾病风险升高相关(aHR 1.64;95% CI 1.48-1.82)。
  • 强直性脊柱炎患者心血管疾病发病率为16.9/1000人年,非强直性脊柱炎对照为13.8/1000人年。

核心结论

  • 强直性脊柱炎患者长期使用非甾体抗炎药的心血管风险可能不如一般人群那样有害。

研究设计与样本

  • 全国性人群队列研究,使用韩国国民健康保险数据库数据。
  • 纳入2010年1月至2018年12月新诊断强直性脊柱炎且无既往心血管疾病的≥18岁患者19775例。
  • 按年龄、性别和索引年份随机匹配无强直性脊柱炎对照59325例。
  • 长期使用非甾体抗炎药定义为累积限定日剂量>365。
  • 主要结局为心血管疾病,即缺血性心脏病、卒中或充血性心力衰竭的复合结局。

主要发现

  • 强直性脊柱炎患者心血管疾病新发1663例,发病率16.9/1000人年;非强直性脊柱炎对照新发4308例,发病率13.8/1000人年。
  • 非强直性脊柱炎对照长期使用非甾体抗炎药与心血管疾病风险升高相关(aHR 1.64;95% CI 1.48-1.82)。
  • 强直性脊柱炎患者长期使用非甾体抗炎药未增加心血管疾病风险(aHR 1.06;95% CI 0.94-1.20;校正年龄、性别、社会经济状况、BMI、吸烟状态、高血压、糖尿病、高脂血症和TNF抑制剂使用)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the risk of cardiovascular disease associated with long-term use of NSAIDs in a large real-world AS cohort. METHODS: This nationwide population-based cohort study used data from the Korean National Health Insurance Database. Patients aged ≥18 years old who were newly diagnosed with AS without prior cardiovascular disease between January 2010 and December 2018 were included in this study. Controls without AS were randomly selected by age, sex and index year. The primary outcome was cardiovascular disease, a composite outcome of ischaemic heart disease, stroke or congestive heart failure. Long-term use of NSAIDs was defined as use of NSAIDs for >365 cumulative defined daily doses. The association between long-term use of NSAIDs and incident cardiovascular disease was examined in both AS and non-AS populations. RESULTS: Among 19 775 patients with AS and 59 325 matched controls without AS, there were 1663 and 4308 incident cases of cardiovascular disease, showing an incidence of 16.9 and 13.8 per 1000 person-years, respectively. Long-term use of NSAIDs was associated with increased risk of cardiovascular disease in non-AS controls [adjusted hazard ratio (aHR) 1.64; 95% CI 1.48-1.82]. In contrast, long-term use of NSAIDs did not increase the risk of cardiovascular disease in AS patients (aHR 1.06; 95% CI 0.94-1.20; adjusted for age, sex, socioeconomic status, BMI, smoking status, hypertension, diabetes, hyperlipidemia and TNF inhibitor use). CONCLUSION: Prolonged NSAID treatment in AS patients may not be as harmful as in the general population regarding cardiovascular risk.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kim JW, Yoon JS, Park S, et al. Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis. Rheumatology (Oxford). 2025. PMID: 38216768. doi:10.1093/rheumatology/kead684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。